Abstract: https://www.acpjournals.org/doi/10.7326/M23-1341
URL goes live when the embargo lifts
More than 1 in 3 U.S. adults is overdue for CRC screening. Receiving a clinician recommendation is the strongest and most consistent determinant of CRC screening participation. Lack of clinician recommendation may contribute to low uptake of CRC screening, but the magnitude of this problem is unknown.
Researchers from the American Cancer Society, Surveillance and Health Equity Science pooled nationally representative data from the 2019 and 2021 National Health Interview Survey to estimate, the prevalence of receiving a clinician recommendation for CRC screening among underscreened U.S. adults, overall and by demographic, socioeconomic, and health care access characteristics. The analysis included 5,022 adults who were eligible and overdue for CRC screening and had a wellness visit in the past year. Overall, only about a quarter of respondents reported receiving a clinician recommendation for CRC screening and the rate of recommendation was lowest among marginalized racial/ethnic and socioeconomic groups. The authors suggest that interventions are needed to remove barriers that prevent effective counseling on CRC prevention.